Phase 3 Uveitis Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are 18 years old or older
• You have been diagnosed with Behçet's Syndrome (BS) based on recognised international diagnostic standards
• You have been diagnosed with a deep vein blood clot (either for the first time or as a return of a previous clot), confirmed by an imaging scan such as an ultrasound, CT scan, or MRI
• You are willing and able to sign a consent form agreeing to take part
• If you are a woman who could become pregnant, you must have a negative pregnancy test before starting treatment and agree to use a reliable form of contraception throughout the trial (such as abstinence, hormonal contraception, an IUD, or other approved methods)
• You are covered by a social security or health insurance system (including universal medical coverage)

Who may not be able to join:

• You have another medical condition apart from your blood clot that requires you to take blood-thinning medication (for example, an irregular heartbeat called atrial fibrillation)
• You are currently bleeding or are at high risk of bleeding, which would make blood-thinning treatment unsafe for you
• You only have a clot in a surface vein (superficial vein) with no deeper clot involvement
• You are currently pregnant or breastfeeding
• You have been taking high-dose steroid tablets (more than 20mg of prednisone or equivalent daily for more than 6 weeks, or more than 4000mg of methylprednisolone in the 4 weeks before joining the trial)
• You have already been taking blood-thinning medication for more than 4 weeks before joining the trial
• You have severe long-term kidney problems (confirm with trial site) or serious liver disease that affects your blood's ability to clot
• Your platelet count (cells that help blood clot) is too low (below a certain level — confirm with trial site)
• Your treatment with biological therapy or immune-suppressing medication has been changed or had its dose adjusted in the month before joining the trial
• You have a known allergy or medical reason that prevents you from safely taking corticosteroids (steroids) or a blood-thinning drug called Rivaroxaban
• You are currently taking part in another clinical trial, or are still within a waiting period after finishing a previous trial

Important: Always verify eligibility with the trial site directly before applying.